Products for Research Use Only

Anticancer agent 265

CAT: 0804-HY-I0450-01Size: 1 gDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-I0450-01Size:1 g
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Anticancer agent 265 (compound 1) is an anticancer compound. Anticancer agent 265 exhibits in vitro anticancer activity against three human bone cancer lines, U2OS, Saos-2, and GC9811, with IC50 values ​​of 13.1, 11.7, and 14.6 μM, respectively[1].
CAS Number
184177-83-1
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Drug Derivative
Related Pathways
Others
Field of Research
Cancer
Purity
99.74
Smiles
O=C1N(C2=CC=C(N3CCN(C4=CC=C(O)C=C4)CC3)C=C2)C=NN1[C@@H](CC)[C@@H](OCC5=CC=CC=C5)C
Molecular Formula
C30H35N5O3
Molecular Weight
513.63
Precautions
H302, H315, H319, H335
References & Citations
[1]G Lv, et al. Synthesis, crystal structure, anti-bone cancer activity and molecular docking investigations of the heterocyclic compound 1- ((2S, 3S) -2- (benzyloxy) pentan-3-yl) -4- (4- (4- (4-hydroxyphenyl) piperazin-1-yl) phenyl) -1H-1, 2, 4-triazol-5 (4H) -one. Journal of Structural Chemistry 60.7 (2019) : 1173-1179.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported